Utilization of plasmonic and photonic crystal nanostructures for enhanced micro- and nanoparticle manipulation.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3230218)

Published in J Vis Exp on September 27, 2011

Authors

Cameron S Simmons1, Emily Christine Knouf, Muneesh Tewari, Lih Y Lin

Author Affiliations

1: Electrical Engineering Department, University of Washington, USA.

Articles by these authors

Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65

The accessible chromatin landscape of the human genome. Nature (2012) 16.86

A map of the interactome network of the metazoan C. elegans. Science (2004) 15.60

Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res (2003) 14.79

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods (2010) 6.25

Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet (2007) 4.69

MicroRNA profiling: approaches and considerations. Nat Rev Genet (2012) 4.39

Functional genomic analysis of RNA interference in C. elegans. Science (2005) 4.36

Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods (2009) 4.34

Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods (2013) 3.63

Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol (2009) 3.16

MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells (2008) 3.14

Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res (2009) 2.54

Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat Methods (2009) 2.50

HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One (2009) 2.37

Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res (2011) 2.34

The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med (2006) 2.13

Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell (2009) 2.09

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol (2009) 1.84

Digital genomic quantification of tumor-infiltrating lymphocytes. Sci Transl Med (2013) 1.72

Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One (2013) 1.71

The clinical applications of a systems approach. PLoS Med (2006) 1.44

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. Am J Pathol (2011) 1.33

MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res (2011) 1.33

The 14-3-3 protein FTT-2 regulates DAF-16 in Caenorhabditis elegans. Dev Biol (2006) 1.27

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PLoS One (2013) 1.23

An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res (2011) 1.08

MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer (2010) 1.05

Derivation, characterization, and in vitro differentiation of canine embryonic stem cells. Stem Cells (2007) 1.02

Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity. Mol Cancer Res (2013) 1.01

Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. Am J Epidemiol (2014) 1.00

The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut (2010) 0.99

Optical manipulation of micron/submicron sized particles and biomolecules through plasmonics. Opt Express (2008) 0.91

Subdiffraction photon guidance by quantum-dot cascades. Nano Lett (2006) 0.91

Remote switching of cellular activity and cell signaling using light in conjunction with quantum dots. Biomed Opt Express (2012) 0.88

Intact microRNA analysis using high resolution mass spectrometry. J Am Soc Mass Spectrom (2013) 0.86

Nanostructure-enhanced laser tweezers for efficient trapping and alignment of particles. Opt Express (2010) 0.86

Large dielectrophoresis force and torque induced by localized surface plasmon resonance of Au nanoparticle array. Opt Lett (2007) 0.86

The human TUT1 nucleotidyl transferase as a global regulator of microRNA abundance. PLoS One (2013) 0.86

Diffractive catheter for ultrahigh-resolution spectral-domain volumetric OCT imaging. Opt Lett (2014) 0.83

Solution-processed photodetectors from colloidal silicon nano/micro particle composite. Opt Express (2010) 0.82

Comparison of cross-talk effects between colloidal quantum dot and conventional waveguides. Opt Lett (2007) 0.82

Activation of the MEK-S6 pathway in high-grade ovarian cancers. Appl Immunohistochem Mol Morphol (2010) 0.82

Scalable nano-particle assembly by efficient light-induced concentration and fusion. Opt Express (2008) 0.81

Dynamic focus-tracking MEMS scanning micromirror with low actuation voltages for endoscopic imaging. Opt Express (2013) 0.80

Nanoscale waveguiding methods. Nanoscale Res Lett (2007) 0.80

Red-emitting silicon quantum dot phosphors in warm white LEDs with excellent color rendering. Opt Express (2014) 0.79

Two-dimensional array self-assembled quantum dot sub-diffraction waveguides with low loss and low crosstalk. Nanotechnology (2008) 0.77

Low power laser induced microfluidic mixing through localized surface plasmon. Conf Proc IEEE Eng Med Biol Soc (2007) 0.77

Brightly photoluminescent phosphor materials based on silicon quantum dots with oxide shell passivation. Opt Express (2012) 0.76

A functional extracellular transcriptome in animals? Implications for biology, disease and medicine. Genome Biol (2015) 0.76

Synthesis and characterization of anti-EGFR fluorescent nanoparticles for optical molecular imaging. Bioconjug Chem (2013) 0.76

A Novel Health Information Technology Communication System to Increase Caregiver Activation in the Context of Hospital-Based Pediatric Hematopoietic Cell Transplantation: A Pilot Study. JMIR Res Protoc (2015) 0.75

Correction: Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer. PLoS One (2016) 0.75

New opto-plasmonic tweezers for manipulation and rotation of biological cells--design and fabrication. Conf Proc IEEE Eng Med Biol Soc (2006) 0.75

Exploring spatial resolution in high-sensitivity nanogap quantum dot photodetectors. Opt Lett (2012) 0.75

Red-emitting silicon quantum dot phosphors in warm white LEDs with excellent color rendering. Opt Express (2014) 0.75

Highly stable cesium lead iodide perovskite quantum dot light-emitting diodes. Nanotechnology (2017) 0.75

Fluorescent porous silicon biological probes with high quantum efficiency and stability. Opt Express (2014) 0.75

Surface passivation dependent photoluminescence from silicon quantum dot phosphors. Opt Lett (2012) 0.75